Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

GEMITA® CONCENTRATE FOR SOLUTION FOR INFUSION 38MG/ML - HSA Drug Approval Details

Approvals/HSA/GEMITA® CONCENTRATE FOR SOLUTION FOR INFUSION 38MG/ML

Approved

THERAPEUTIC

GEMITA® CONCENTRATE FOR SOLUTION FOR INFUSION 38MG/ML

Fresenius Kabi Oncology Limited (INDIA)🇸🇬 Health Sciences Authority

Approval Date: Feb 20, 2020
Approval ID: d219058e49cce612
Company: Fresenius Kabi Oncology Limited (INDIA)
Type: Therapeutic

Approval Details

Approval Id: d219058e49cce612
Drug Name: GEMITA® CONCENTRATE FOR SOLUTION FOR INFUSION 38MG/ML
Product Name: GEMITA® CONCENTRATE FOR SOLUTION FOR INFUSION 38MG/ML
Approval Number: SIN15887P
Approval Date: 2020-02-20
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder: FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INFUSION, SOLUTION CONCENTRATE
Route Of Administration: INTRAVENOUS
Atc Code: ‎L01BC05
Atc Item Name: x‎l 01 bc 05
Pharma Manufacturer Name: FRESENIUS KABI (SINGAPORE) PTE LTD

Active Ingredients

Gemcitabine Hydrochloride 43.2668mg/ml eqv to Gemcitabine

38mg/ml

GEMCITABINE HYDROCHLORIDE 43.2668 MG/ML EQV TO GEMCITABINE

38 MG/ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Feb 20, 2020

Approval ID

d219058e49cce612

Type

Therapeutic

Back to HSA Approvals